![Fahad Khaled Saleh Al-Ghunaim](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fahad Khaled Saleh Al-Ghunaim
Vorstandsvorsitzender bei First Qatar Real Estate Development Co. KSCC
Ursprung des Netzwerks ersten Grades von Fahad Khaled Saleh Al-Ghunaim
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
First Qatar Real Estate Development Co. KSCC
![]() First Qatar Real Estate Development Co. KSCC Real Estate DevelopmentFinance First Qatar Real Estate Development Co. KSCC provides real estate development and asset management services. Its services include real estate development, finance and investment, property management and facility management, property feasibility studies, sales, promotion and marketing, sales agent network, design concept and interior design, project and construction management, hospitality and leisure. The company was founded in 2005 and is headquartered in Kuwait City, Kuwait.
3
| Holding Company | Real Estate Development | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Fahad Khaled Saleh Al-Ghunaim
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Ahli United Bank (UK) Plc
![]() Ahli United Bank (UK) Plc Major BanksFinance Ahli United Bank (UK) Plc provides commercial and retail banking services. It provides deposit products including savings, checking, and fixed deposit accounts; lending products such as property finance, business loans, residential mortgages, and trade finance; and online banking services. The company was founded in 1966 and is headquartered in London, the United Kingdom. | Major Banks | Director/Board Member | |
KUWAIT FINANCE HOUSE K.S.C.P. | Regional Banks | Director/Board Member | |
Kuwait University | College/University | Undergraduate Degree | |
CanImGuide Therapeutics AB
![]() CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Kuwaiti Digital Computer Co. | Chairman | ||
ABB LLC (Qatar) | Director of Finance/CFO | ||
Al Tadamon Al Kuwaitiya Holding Co. | Director/Board Member | ||
Mohamed Bin Yousef Al Nisf & Partners | Chief Executive Officer | ||
Trading & Industrial Equipment Co. | Chief Executive Officer |
Statistik
International
Kuwait | 6 |
Vereinigtes Königreich | 2 |
Schweden | 2 |
Katar | 2 |
Vereinigte Arabische Emirate | 2 |
Sektoral
Finance | 3 |
Consumer Services | 2 |
Health Technology | 2 |
Operativ
Director/Board Member | 6 |
Chief Executive Officer | 2 |
Undergraduate Degree | 1 |
Chairman | 1 |
Corporate Officer/Principal | 1 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Fahad Khaled Saleh Al-Ghunaim
- Unternehmensverbindungen